265 related articles for article (PubMed ID: 22466083)
1. Isoprenoid biosynthesis in bacterial pathogens.
Heuston S; Begley M; Gahan CGM; Hill C
Microbiology (Reading); 2012 Jun; 158(Pt 6):1389-1401. PubMed ID: 22466083
[TBL] [Abstract][Full Text] [Related]
2. Metabolic plasticity for isoprenoid biosynthesis in bacteria.
Pérez-Gil J; Rodríguez-Concepción M
Biochem J; 2013 May; 452(1):19-25. PubMed ID: 23614721
[TBL] [Abstract][Full Text] [Related]
3. The interplay between classical and alternative isoprenoid biosynthesis controls gammadelta T cell bioactivity of Listeria monocytogenes.
Begley M; Gahan CG; Kollas AK; Hintz M; Hill C; Jomaa H; Eberl M
FEBS Lett; 2004 Mar; 561(1-3):99-104. PubMed ID: 15013758
[TBL] [Abstract][Full Text] [Related]
4. On the Origin of Isoprenoid Biosynthesis.
Hoshino Y; Gaucher EA
Mol Biol Evol; 2018 Sep; 35(9):2185-2197. PubMed ID: 29905874
[TBL] [Abstract][Full Text] [Related]
5. Origins and early evolution of the mevalonate pathway of isoprenoid biosynthesis in the three domains of life.
Lombard J; Moreira D
Mol Biol Evol; 2011 Jan; 28(1):87-99. PubMed ID: 20651049
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the isoprenoid biosynthesis pathways in Listeria monocytogenes reveals a role for the alternative 2-C-methyl-D-erythritol 4-phosphate pathway in murine infection.
Begley M; Bron PA; Heuston S; Casey PG; Englert N; Wiesner J; Jomaa H; Gahan CG; Hill C
Infect Immun; 2008 Nov; 76(11):5392-401. PubMed ID: 18765739
[TBL] [Abstract][Full Text] [Related]
7. Network analysis of the MVA and MEP pathways for isoprenoid synthesis.
Vranová E; Coman D; Gruissem W
Annu Rev Plant Biol; 2013; 64():665-700. PubMed ID: 23451776
[TBL] [Abstract][Full Text] [Related]
8. Methylerythritol phosphate pathway to isoprenoids: kinetic modeling and in silico enzyme inhibitions in Plasmodium falciparum.
Singh VK; Ghosh I
FEBS Lett; 2013 Sep; 587(17):2806-17. PubMed ID: 23816706
[TBL] [Abstract][Full Text] [Related]
9. HmgR, a key enzyme in the mevalonate pathway for isoprenoid biosynthesis, is essential for growth of Listeria monocytogenes EGDe.
Heuston S; Begley M; Davey MS; Eberl M; Casey PG; Hill C; Gahan CGM
Microbiology (Reading); 2012 Jul; 158(Pt 7):1684-1693. PubMed ID: 22504435
[TBL] [Abstract][Full Text] [Related]
10. Isoprenoid biosynthesis in Archaea--biochemical and evolutionary implications.
Matsumi R; Atomi H; Driessen AJ; van der Oost J
Res Microbiol; 2011 Jan; 162(1):39-52. PubMed ID: 21034816
[TBL] [Abstract][Full Text] [Related]
11. Lethal mutations in the isoprenoid pathway of Salmonella enterica.
Cornish RM; Roth JR; Poulter CD
J Bacteriol; 2006 Feb; 188(4):1444-50. PubMed ID: 16452427
[TBL] [Abstract][Full Text] [Related]
12. Isoprenoid biosynthetic pathways as anti-infective drug targets.
Rohdich F; Bacher A; Eisenreich W
Biochem Soc Trans; 2005 Aug; 33(Pt 4):785-91. PubMed ID: 16042599
[TBL] [Abstract][Full Text] [Related]
13. Homology modeling of Mycobacterium tuberculosis 2C-methyl-D-erythritol-4-phosphate cytidylyltransferase, the third enzyme in the MEP pathway for isoprenoid biosynthesis.
Obiol-Pardo C; Cordero A; Rubio-Martinez J; Imperial S
J Mol Model; 2010 Jun; 16(6):1061-73. PubMed ID: 19916033
[TBL] [Abstract][Full Text] [Related]
14. The Methylerythritol Phosphate Pathway to Isoprenoids.
Frank A; Groll M
Chem Rev; 2017 Apr; 117(8):5675-5703. PubMed ID: 27995802
[TBL] [Abstract][Full Text] [Related]
15. Toxoplasma gondii apicoplast-resident ferredoxin is an essential electron transfer protein for the MEP isoprenoid-biosynthetic pathway.
Henkel S; Frohnecke N; Maus D; McConville MJ; Laue M; Blume M; Seeber F
J Biol Chem; 2022 Jan; 298(1):101468. PubMed ID: 34896149
[TBL] [Abstract][Full Text] [Related]
16. Isoprenoid biosynthesis via the mevalonate-independent route, a novel target for antibacterial drugs?
Rohmer M
Prog Drug Res; 1998; 50():135-54. PubMed ID: 9670778
[TBL] [Abstract][Full Text] [Related]
17. A Metabolic Dependency for Host Isoprenoids in the Obligate Intracellular Pathogen Rickettsia parkeri Underlies a Sensitivity to the Statin Class of Host-Targeted Therapeutics.
Ahyong V; Berdan CA; Burke TP; Nomura DK; Welch MD
mSphere; 2019 Nov; 4(6):. PubMed ID: 31722991
[TBL] [Abstract][Full Text] [Related]
18. Methylerythritol phosphate pathway of isoprenoid biosynthesis.
Zhao L; Chang WC; Xiao Y; Liu HW; Liu P
Annu Rev Biochem; 2013; 82():497-530. PubMed ID: 23746261
[TBL] [Abstract][Full Text] [Related]
19. Strategies of isoprenoids production in engineered bacteria.
Li Y; Wang G
J Appl Microbiol; 2016 Oct; 121(4):932-40. PubMed ID: 27428054
[TBL] [Abstract][Full Text] [Related]
20. Isoprenoid biosynthesis as a novel target for antibacterial and antiparasitic drugs.
Rohmer M; Grosdemange-Billiard C; Seemann M; Tritsch D
Curr Opin Investig Drugs; 2004 Feb; 5(2):154-62. PubMed ID: 15043389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
